MarketPulse — Real-Time Financial News & Market Analysis

Seacoast Banking EVP sells $416K in shares despite company's seven quarters of revenue growth and $4.4B acquisition. Stock down 13.44% in five years amid geographic concentration concerns.

Pure-play quantum stocks down 30% remain overvalued with severe cash burn. Big Tech giants Alphabet and IBM offer better quantum exposure through profitable core businesses.

Google Cloud's 48% growth and Symbotic's profitability turnaround offer compelling value as AI stocks face selling pressure from growth concerns.

CIA tracked Iran's Khamenei for months as tensions spike. Oil prices surge amid Strait of Hormuz disruption fears; 700+ Dubai flights cancelled.

Greg Abel will oversee nearly all of Berkshire Hathaway's $320B equity portfolio and $373B cash reserve, signaling continuity in Buffett's capital allocation strategy.

Domino's claims 22nd consecutive Customer Loyalty crown. Stock returned 6,400% since 2004 IPO.

Duolingo faces 2026 inflection point: converting massive user base profitably while maintaining engagement through premium AI tiers and improved subscriber economics.

Nvidia remains undervalued despite massive gains, supported by industry-leading margins, AI leadership, and aggressive $40.1B buyback program.

Ubisoft investor's 2022 acquisition bet collapsed 90% by 2026 after Tencent's strategic holding investment and franchise spinoff dismantled takeover premiums and destroyed shareholder value.

Ten large-cap stocks plunged last week, led by First Solar's 18.6% drop on weak guidance and Novo Nordisk's 6.6% decline over pricing concerns.

Rhythm Pharmaceuticals reports positive Phase 3 data for setmelanotide treating acquired hypothalamic obesity, with FDA decision expected March 2026.

Realty Income and Main Street Capital offer high dividend yields with proven track records of consistent growth, appealing to income-focused investors seeking stable returns.

Four largest tech companies plan $655B AI infrastructure spending this year, creating opportunities across chipmakers, memory firms, foundries, cloud providers, and energy sectors.

Ancora Advisors establishes $148M position in Americold Realty Trust ($COLD) following 42% stock decline, citing attractive valuation and stable warehouse operations.

Pfizer's reasonable valuation, robust pipeline, and 6.4% dividend yield offer disciplined returns versus speculative biotech like Regencell, whose 21,000% surge lacks fundamental justification.

Class action lawsuit filed against $UGXY alleging securities fraud related to setrusumab clinical trial data. Investors from August 2023 to December 2025 eligible.

Class action lawsuit filed against Ardent Health for alleged $57.5M EBITDA overstatement and revenue misstatements tied to new accounting systems and sector headwinds.

Class action lawsuit filed against $LAKE alleging executives made false statements about Pacific Helmets and Jolly business performance while concealing operational issues.

Class action filed against $FRMI alleging materially false statements about Project Matador tenant demand and overstated financial prospects since October 2025 IPO.

uniQure faces securities class action over alleged misrepresentations regarding FDA approval status of Huntington's Disease trial design and regulatory timeline delays. Lead plaintiff deadline April 13, 2026.